---  
layout: startup_page  
title: "Flindr Therapeutics"  
id: "flindrtx.com"  
permalink: "/flindrtherapeuticsflindrtx.com04242024/"  
website: "https://flindrtx.com/"  
funding_round: "Series A"  
funding_amount: "€20M"  
investors: "V-Bio Ventures, Johnson & Johnson Innovation – JJDC, Inc., QBIC Fund, Flanders Future Tech Fund, Curie Capital, Oncode Oncology Bridge Fund, Swanbridge, Brabantse Ontwikkelings Maatschappij (BOM)"  
about: "Flindr Therapeutics is a precision oncology therapeutics company developing first-in-class, small molecule inhibitors for cancer treatment. Their lead asset targets the RNF31 protein, and they utilize the \"ImmunoGram Drug Discovery Engine\" to identify and develop these inhibitors. The company focuses on translating precision targets into precision therapies to improve patient outcomes."  
markets: "Oncology, Biotechnology, Pharmaceuticals"  
hq: "Oss, North Brabant, Netherlands"  
founded_year: "2020"  
linkedin: "https://www.linkedin.com/company/flindr-therapeutics/"  
twitter: "https://twitter.com/FlindrT240408"  
instagram: ""  
facebook: ""  
crunchbase: "https://www.crunchbase.com/organization/immagene"  
pitchbook: "https://pitchbook.com/profiles/company/443258-29"  

date_display: "24-Apr-2024"  
date: "2024-04-24"

# SEO Optimization  
meta_title: "Flindr Therapeutics - Series A Funding (€20M)"  
meta_description: "Flindr Therapeutics, Flindr Therapeutics is a precision oncology therapeutics company developing first-in-class, small molecule inhibitors for cancer treatment. Their lead..."  
meta_keywords: "Flindr Therapeutics, Oncology, Biotechnology, Pharmaceuticals, Series A funding"  
canonical_url: "https://startup.projectstartups.com/flindrtherapeuticsflindrtx.com04242024/"  
---